IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQVIA Holdings Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Technology & Analytics Solutions Segment Profit

Technology & Analytics Solutions Segment Profit % Chg.

Technology & Analytics Solutions Segment Profit Common Size

Research & Development Solutions Segment Profit

Research & Development Solutions Segment Profit % Chg.

Research & Development Solutions Segment Profit Common Size

Contract Sales & Medical Solutions Segment Profit

Contract Sales & Medical Solutions Segment Profit % Chg.

Contract Sales & Medical Solutions Segment Profit Common Size

Other EBIT

Other EBIT % Chg.

Other EBIT Common Size

Total EBIT

Total EBIT Common Size

Total EBIT % Chg.

Research & Development Solutions Backlog

Research & Development Solutions Backlog % Chg.

Key Performance Indicators

Technology & Analytics Solutions Revenue

Technology & Analytics Solutions Revenue % Chg.

Technology & Analytics Solutions Revenue Common Size

Research & Development Solutions Revenue

Research & Development Solutions Revenue % Chg.

Research & Development Solutions Revenue Common Size

Contract Sales & Medical Solutions Revenue

Contract Sales & Medical Solutions Revenue % Chg.

Contract Sales & Medical Solutions Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	Sep '25	Jun '25
Technology & Analytics Solutions Revenue	1,631	1,628
Research & Development Solutions Revenue	2,260	2,201
Contract Sales & Medical Solutions Revenue	209	188
Total Revenue	4,100	4,017

EBIT	Sep '25	Jun '25
Technology & Analytics Solutions Segment Profit	370	389
Research & Development Solutions Segment Profit	496	451
Contract Sales & Medical Solutions Segment Profit	13	12
Other EBIT	-326	-346
Total EBIT	553	506